SPRO and KKR Related Headlines

Go Back

Jul 14, 2026 06:21AM Spero Therapeutics shares fall after $105M KKR deal

Jul 14, 2026 06:04AM Spero Therapeutics secures $105M royalty-backed financing deal

Jul 14, 2026 06:02AM Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

SPRO and KKR Related Press Releases

Go Back

Jul 14, 2026 06:02AM Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

SPRO and KKR Related SEC Filings

Go Back